Dr. Laura James
Laura James, director of the UAMS Translational Research Institute, has been named to the national Clinical and Translational Science Awards Program Steering Committee.
The CTSA Program is administered by the National Center for Advancing Translational Sciences at the National Institutes of Health. The UAMS Translational Research Institute received a five-year, $24.2 million CTSA grant in July and is one of more than 60 CTSA-supported institutions nationally.
James will serve for three years. As one of the committee’s members, she will enable information and idea sharing among her peers in the CTSA program and NCATS leadership to advance clinical and translational science.
James has been director of the institute since 2014 and is UAMS’ associate vice chancellor for clinical and translational research.
She has a 25-year history of translational research in clinical pharmacology and toxicology at UAMS and Arkansas Children’s Hospital. As a clinician-scientist and founder of the startup company Acetaminophen Toxicity Diagnostics LLC, James is leading development of a rapid diagnostic test for acetaminophen liver injury.
She was named inaugural fellow of the Arkansas Research Alliance in 2014.
Sign up for Daily E-news
